The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
Last updated
Peptide Profile

Dapagliflozin: Research, Dosing, and Where to Buy in 2026

A research-first profile for Dapagliflozin (Farxiga), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.

⚕️ US PRESCRIPTION REQUIRED. Dapagliflozin is a prescription medication in the United States. Prescription and controlled-substance rules differ by country, so check your local laws before any purchase or use. Information on this page is educational and not medical advice. Consult a licensed prescribing physician.
Quick Answer

Dapagliflozin is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 15 PubMed-cited papers, 3 attributed expert mentions, and 4 transcript dosing protocols for Dapagliflozin, each linked to its source.

Key Facts
Pharmaceutical
  • Also indexed as Farxiga.
  • 4 aggregated dosing-protocol mentions from source transcripts.
  • 15 PubMed-indexed citations listed in the research table below.
  • 0 vendor recommendations captured from named experts.
  • Evidence level in this entry is marked as fda_approved.
Sourced to expert
Check vendor COA
Verify dose w/ clinician

What is Dapagliflozin?

Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.

Experts on background and overview · 2 cited mentions

"50 to 100 mg injectable data and pre-workout five times a week."
Vigorous Steve · Low-Dose MENT Year-Round, Melt Love Handle Fat,... @ 1:36:31
"Empagliflozin and dapagliflozin are the only compounds that really show longevity benefits."
Vigorous Steve · Ozempic Issues, Injectable Anadrol, Shrink Gyno, Hypo On... @ 49:51

What is Dapagliflozin researched for?

SGLT2 inhibitor with longevity benefits, similar use case as empagliflozin.

Dapagliflozin Dosing Protocols

The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.

SpeakerSourceTimestampProtocolEvidence
Vigorous Steve Low-Dose MENT Year-Round, Melt Love Handle Fat, Injectable YK-11,... 01:36:33 50-100 mg injectable pre-workout 5x/week with cardarine/carnitine stack anecdotal
Vigorous Steve Ozempic Issues, Injectable Anadrol, Shrink Gyno, Hypo On Tren, PIP... 00:50:16 10 mg dapagliflozin before bed alongside GH + injectable carnitine anecdotal
Vigorous Steve Best PED Use (Competitive vs. Lifestyle) & All Things to Avoid Death... 01:20:48 Steve reported using 10-25 mg before bed (anecdotal). anecdotal
Leo and Longevity (Lucie) How to Improve Cognitive Brain Function from a Neuroscientist 00:22:35 5 mg in the morning on empty stomach anecdotal

Where to Buy Dapagliflozin in 2026

No tracked vendor recommendations for Dapagliflozin yet. See our vendor directory.

Side Effects and Safety

Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.

What Experts Say

1 expert across our source library discuss Dapagliflozin. Each entry is that expert’s most context-rich mention: click to watch it at the exact timestamp in the original video. Quotes are also emitted as Schema.org Quotation JSON-LD for AI assistants.

  1. Vigorous Steve · Low-Dose MENT Year-Round, Melt Love Handle Fat,...Watch @ 1:36:31 ↗

    “50 to 100 mg injectable data and pre-workout five times a week.”

See 2 more expert mentions →
  1. Vigorous Steve · Ozempic Issues, Injectable Anadrol, Shrink Gyno, Hypo...Watch @ 49:51 ↗

    “Empagliflozin and dapagliflozin are the only compounds that really show longevity benefits.”

  2. Vigorous Steve · Best PED Use (Competitive vs. Lifestyle) & All Things...Watch @ 1:20:48 ↗

    “Improfllosen debofloin 10 milligs 25 milligrams before bed. I think that's the best thing people can look into if they want to stay dry.”

User Reviews

User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.

Research Efficacy Snapshot

Published efficacy percentages cited in PubMed trials and named-expert reports about Dapagliflozin. Each line links to the original source.

  • "For the composite of cardiovascular death or hospitalization for heart failure, Sotagliflozin demonstrated the most substantial risk reduction (OR = 0.49; 95% CI 0.39, 0.62)." · Chen XR et al, 2026 PubMed
  • "This agent also showed significant efficacy against heart failure readmission (OR = 0.53; 95% CI 0.45, 0.63)." · Chen XR et al, 2026 PubMed
  • "Notably, Dapagliflozin improved LVEF more effectively than controls (MD -2.94%; 95% CI -3.89, -1.99)." · Chen XR et al, 2026 PubMed
  • "placebo (SMD -0.61; 95% CI -0.91, -0.31)." · Chen XR et al, 2026 PubMed
  • "Empagliflozin additionally exhibited superior preservation of eGFR (MD -2.08; 95% CI -3.38, -0.78), whereas Vildagliptin achieved the greatest reduction in HbA1c (MD -0.62%; 95% CI -1.12, -0.12)." · Chen XR et al, 2026 PubMed
  • "**RESULTS**: At baseline, hypomagnesemia was present in 26.5% of dapagliflozin-treated patients and 22.9% of controls." · Guillot D et al, 2026 PubMed
  • "The primary endpoint was the change in whole blood passage time (WBPT), measured using a microchannel flow analyzer that simulates precapillary arterioles (7 × 7 μm), with a prespecified noninferiority margin of 6.0 s (15%)." · Nakatani Y et al, 2026 PubMed
  • "**RESULTS**: WBPT changed minimally in the dapagliflozin group (+1.4 s; 95% CI, 0.0-2.9) and slightly decreased in the control group (-0.6 s; 95% CI, -1.9 to 0.6), yielding a between-group difference of 2.0 s (95% CI, -0.2 to 3.9), with the upper bound below the prespecified noninferiority margin." · Nakatani Y et al, 2026 PubMed
  • "Dapagliflozin increased hematocrit and EPO, particularly in participants with lower baseline hematocrit, whereas those with hematocrit >45% showed minimal change." · Nakatani Y et al, 2026 PubMed
  • "A baseline score ≥8 identified lower loop diuretic efficiency (pooled difference -0.12 kg/40 mg, 95% CI -0.18 to -0.06; p < 0.001) despite similar congestion markers at baseline." · Alfonso DM et al, 2026 PubMed

Research and Studies

15 PubMed-indexed papers reference Dapagliflozin. Top 15 shown.

Frequently Asked Questions

Is Dapagliflozin FDA-approved?

Dapagliflozin is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.

What dosing is reported for Dapagliflozin?

This page aggregates 4 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.

How much research has been published on Dapagliflozin?

15 PubMed-indexed paper(s) reference Dapagliflozin in our current research feed. See the Research and Studies section above for citations.